Ayble Health secured $16 million in a Series A round to expand its virtual digestive health clinic model. The round was led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, and Accomplice. The financing underscores investor appetite for digitally delivered care pathways that can expand specialty access without requiring in-person visit capacity. Digestive diseases are among the high-burden conditions where remote triage, monitoring, and protocol-driven management can create measurable efficiencies. For the biotech-adjacent healthcare ecosystem, capital flow into virtual specialty clinics can influence demand patterns for diagnostics, therapeutics, and patient support services. It also highlights how health systems may increasingly partner with startups to manage longitudinal disease. The company’s next steps—whether adding programs for specific GI conditions, expanding clinician staffing, or strengthening payer and provider integrations—will likely determine how quickly the funding translates into scale.